Acetylsalicylic acid Completed Phase 3 Trials for Transient Ischaemic Attack (TIA) / Systemic Embolism / Infarction, Brain Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00235248Aortic Arch Related Cerebral Hazard Trial (ARCH)